Maxwell A M, Jordaan J P
S Afr Med J. 1987 Feb 7;71(3):180.
Two cases of recurrent ovarian adenocarcinoma were resistant to standard combination chemotherapy regimens. Complete response was achieved with salvage therapy comprising cis-platinum 120 mg/m2 intravenously every 3 weeks and VP-16 (etoposide; Bristol-Myers) 200 mg per os weekly.
两例复发性卵巢腺癌患者对标准联合化疗方案耐药。采用挽救性治疗方案取得了完全缓解,该方案为每3周静脉注射顺铂120 mg/m² ,同时每周口服VP-16(依托泊苷;百时美施贵宝公司生产)200 mg。